Medicare

Strategic planningDermatologists must be aware of pending payment reductions and actively oppose Medicare's proposed elimination of global periods for certain procedures.
Report Slams 340B Drug Discount ProgramA Pacific Research Institute report revealed that the 340B program is in desperate need of reform, while 340B Health refutes damaging claims.
Seven Ways to Help Patients Access Costly Cancer DrugsTwo new studies reveal that cost-restraints can keep patients from accessing life-preserving cancer drugs.
Expert Predicts Outlook for Medicare Advantage, Managed MedicaidA KPMG-Leavitt Partners report shows Medicare Advantage and Managed Medicaid are on slightly different trajectories. Expert Ash Shehata shares his predictions for both markets.
Expert Predictions: Generic Drug Costs, Biosimilar Impact, Policy ChangesHow are generic prices changing, how will biosimilars impact costs, and what changes out of Washington should healthcare executives watch? Economics guru Joe Fuhr weighs in.
Blindness gene therapy price tag stirs controversyA patient advocacy group is criticizing the hefty price tag of a new treatment for blindness.
Six things to know about CMS' new bundled payment modelCMS unveiled a voluntary episode bundled payment model, Bundled Payments for Care Improvement Advanced (BPCI Advanced). Here’s six things experts want you to know
Wellness Visits/Pharmacists: Perfect Together
Wellness Visits/Pharmacists: Perfect TogetherStudy finds that patients like wellness visits conducted by pharmacists.
4 benefits of Medicare Annual Wellness VisitsWhat you should know to maximize this specific visit for your patient and for your practice
Two ways to improve health by addressing whole person careBy recognizing and address the needs of the “whole person,” we have an opportunity to improve the health of people across the U.S. Here are two ways to do that.